Hydrodychloroquine (HCQ)

This study is for:

  • participants who are at least 3 years old AND

  • have two or more diabetes-related autoantibodies AND

  • have normal results on an oral glucose tolerance test (OGTT) AND

  • are able to swallow a whole capsule

  • NOT be pregnant or planning to become pregnant while in the study

  • NOT have any medical conditions that might make it unsafe for you to be in this study

About this study

We are testing the drug hydroxychloroquine (HCQ) to see if it can delay or prevent early stage T1D (stage 1) from progressing to abnormal glucose tolerance (stage 2) and ultimately prevent clinical diagnosis (stage 3). HCQ is already used to reduce symptoms and progression of other autoimmune diseases, such as rheumatoid arthritis and lupus. This is the first study to see if it can prevent or delay T1D.

For more information about this study

  • Contact us